JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shlomo Gabbay
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gabbay, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gabbay, S.
Related Collections
Right arrow Cardiac - other

J Thorac Cardiovasc Surg 2009;137:1293-1294
© 2009 The American Association for Thoracic Surgery

Letter to the Editor

Why are the results reported from this center inconsistant with the general experience of 4000 implants and 10 years of follow-up?

Shlomo Gabbay, MD

University Medical and Dentistry of NJ, Department of Cardiothoracic Surgery, New Jersey Medical School, Newark, NJ

The first 20% of the full text of this article appears below.

To the Editor:

The article previously published in the Journal 1Go presents a series of cases of the Shelhigh 2000C (Shelhigh Inc, Union, NJ) aortic valve conduit for the Bentall procedure. Shelhigh Inc appreciates Carrel and colleagues'1Go study of the device and their appreciation for the device's benefits to patients. Although Shelhigh Inc is interested in getting fair clinical feedback on its products, I believe the article was misleading.

Aspects of the article beg important questions, and, in my view, their article lacks clinical context and historical accuracy. I'd like to offer your readers (1) a clearer account of the company's communication with Berne regarding the devices, particularly with regard to surgical technique; (2) a wider clinical perspective on the device; and (3) questions that the article simply begs for an answer.

Shelhigh Inc was not remiss in the close surveillance of its products. Before this publication, the company had not seen most of . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.